Literature DB >> 22047846

[Accuracy of diagnosis of depression in patients with Type 1 diabetes mellitus].

María Teresa Anarte Ortiz1, Mónica Carreira Soler, María Seledad Ruiz de Adana Navas, Francisco Félix Caballero Díaz, Antonio Godoy Ávila, Federico C Soriguer Escofet.   

Abstract

This study assesses the clinical accuracy of physicians (Specialists in Endocrinology and Nutrition: SEN) to make the diagnosis of depression in patients with Type 1 diabetes mellitus (DM1). This study involved 11 SEN physicians, and 153 patients with DM1. The diagnosis of depression was performed using the SCID-1 structured interview and clinical assessment. From the initial sample, 50 patients were randomly selected (imposing the condition that it was included 25 patients with depression and 25 without depression). The results show that clinicians performed a higher percentage of negative diagnoses (patients without depression) than positive ones (patients with depression). A significant percentage of patients with depression were not diagnosed (25%). It therefore seems necessary to provide adequate clinical protocols to evaluate the presence of this disorder in DM1, as well as continuing research into the diagnostic process for clinical decision making.

Entities:  

Mesh:

Year:  2011        PMID: 22047846

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  2 in total

1.  Development and Validation of the Depression Inventory for Type 1 Diabetes (DID-1).

Authors:  Mónica Carreira; María Soledad Ruiz de Adana; Marta Domínguez; Sergio Valdés; Maria Cruz Almaraz; Gabriel Olveira; María Teresa Anarte
Journal:  Int J Environ Res Public Health       Date:  2021-11-28       Impact factor: 3.390

2.  Internet-based Cognitive-behavioral therapy (CBT) for depressive symptomatology in individuals with type 1 diabetes (WEB_TDDI1 study): A randomized controlled trial protocol.

Authors:  Mónica Carreira; María Soledad Ruiz de Adana; José Luis Pinzón; María Teresa Anarte-Ortiz
Journal:  PLoS One       Date:  2022-09-20       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.